Re: Drug Interactions

From: Mats Karlsson Date: December 19, 1997 technical Source: cognigencorp.com
From: Mats Karlsson <mats.karlsson@biof.uu.se> Subject: Re: Drug Interactions Date: 19 Dec 1997 09:17:50 -0500 Cornelia and other nmusers To group by therapeutic area and to group by suspected mechanism of interaction are by no means mutuallly exclusive. I think that the latter in general is the more interesting, but it requires classification of a large number of drugs into classes of e.g. CYP3A4 inhibitors, drugs actively secreted and drugs that are substrates for p-gp. I'm sure that many would be grateful if those that have compiled such listings made them available to others. Maybe the Palo Alto site would be a suitable stoaring place. Mats Karlsson

Thread

View all 13 messages
Dec 16, 1997 Gary Maier NONMEM and identification of drug-drug interactions
Dec 17, 1997 Janet Wade Drug Interactions
Dec 17, 1997 Mats Karlsson Re: NONMEM and identification of drug-drug interactions
Dec 17, 1997 Rene Bruno NONMEM and drug-drug interaction
Dec 17, 1997 Ziad Hussein Re: NONMEM and identification of drug-drug interactions
Dec 17, 1997 Ekaterina Gibiansky RE: NONMEM and identification of drug-drug interactions
Dec 19, 1997 Mats Karlsson RE: NONMEM and identification of drug-drug interactions
Dec 19, 1997 Ziad Hussein RE: NONMEM and identification of drug-drug interactions
Dec 19, 1997 Cornelia Weber Re: Drug Interactions
Dec 19, 1997 Mats Karlsson Re: Drug Interactions
Dec 19, 1997 Ekaterina Gibiansky RE: NONMEM and identification of drug-drug interactions
Dec 19, 1997 Robert Shore Re: Drug Interactions
Dec 19, 1997 Jeff Wald Re: Drug Interactions
← Previous
Next →